Trinucleotide (CAG) repeat length is positively correlated with the degree of DNA fragmentation in Huntington's disease striatum

Neuroscience

Volumn 87, Issue 1, 1998, Pages 49-53

  Butterworth, N J ^a   Williams, L ^b   Bullock, J Y ^a   Love, D R ^b   Faull, R L M ^a   Dragunow, M ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Apoptosis; CAG repeats; DNA fragmentation; Huntington's disease

Indexed keywords

DNA FRAGMENT;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CELL DEATH; GENE EXPRESSION; HUNTINGTON CHOREA; NERVE CELL DEGENERATION; PRIORITY JOURNAL; TRINUCLEOTIDE REPEAT;

ADULT; AGED; ALZHEIMER DISEASE; CORPUS STRIATUM; DNA FRAGMENTATION; FEMALE; HUMANS; HUNTINGTON DISEASE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; TRINUCLEOTIDE REPEATS;

EID: 0032581167     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00129-8     Document Type: Article

References (22)

1. Andrew S. F., Goldberg Y. P., Kremer B., Telenius H., Theilmann J., Adam S., Starr F., Squineri F., Lin H., Kalchman M. A., Graham R. K., Hayden M. R. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington disease. Nature Genet. 4:1993;398-403.
2. Braak H., Braak E. Neuronal types in the striatum of man. Cell Tiss. Res. 227:1982;319-342.
3. Brandt J., Bylsma F. W., Gross R., Stine O. C., Ranen N., Ross C. A. Trinucleotide repeat length and clinical progression in Huntington's disease. Neurology. 46:1996;527-531.
4. Cotman C. W., Anderson A. J. A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Molec. Neurobiol. 10:1995;19-45.
5. Dragunow M., Faull R. L., Lawlor P., Beilharz E. J., Singleton K., Walker E. B., Mee E. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. NeuroReport. 6:1995;1053-1057.
6. Dragunow M., Preston K. The role of inducible transcription factors in apoptotic nerve cell death. Brain Res. Rev. 21:1995;1-28.
7. Furtado S., Suchowersky O., Rewcastle N. B., Graham L., Klimek M. L., Garber A. Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease. Ann. Neurol. 39:1996;134-137.
8. Gavrieli Y. S. Y., Ben-Sasson S. A. Identification of programmed cell death in situ via a specific labelling of DNA fragmentation. J. Cell Biol. 119:1992;493-501.
9. Goldberg Y. P., Nicholson D. W., Rasper D. M., Kalchman M. A., Koide H. B., Graham R. K., Bromm M., Kazemi-Esfarjani P., Thornberry N. A., Vaillancourt J. P., Hayden M. R. Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nature Genet. 13:1996;442-449.
10. Grashl-Kraupp B., Ruttkay-Nedecky B., Koudelka H., Bukowska K., Bursch W., Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology. 21:1995;1465-1468.
11. Graveland G. A., Williams R. S., DiFiglia M. Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. Science. 227:1995;770-773.
12. Gusella J. F., MacDonald M. E. Huntington's disease. Semin. Cell Biol. 6:1995;21-28.
13. Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983.
14. Kowall N. W., Ferrante R. J., Martin J. B. Patterns of cell loss in Huntington's disease. Trends Neurosci. 10:1987;24-29.
15. Mundle S. D., Raza A. The two in situ techniques do not differentiate between apoptosis and necrosis but rather reveal distinct patterns of DNA fragmentation in apoptosis. Lab. Invest. 72:1995;611-613.
16. Portera-Cailliau C., Hedreen J. C., Price D. L., Koliatsos V. E. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J. Neurosci. 15:1995;3775-3787.
17. Sharp A. H., Ross C. A. Neurobiology of Huntington's disease. Neurobiol. Dis. 3:1996;3-15.
18. Stine O. C., Pleasant N., Franz M. I., Abbott M. H., Folstein S. F., Ross C. A. Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15. Hum. molec. Genet. 2:1993;1547-1549.
19. Thomas L. B., Gates D. J., Richfield E. K., O'Brien T. F., Schweitzer J. B., Steindler D. A. DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions. Expl Neurol. 133:1995;265-272.
20. Vonsattel J. P., Myers R. H., Stevens T. J., Ferrante R. J., Bird E. D., Richardson E. P. J. Neuropathological classification of Huntington's disease. J. Neuropath. exp. Neurol. 44:1984;559-577.
21. Whitefield J. E., Williams L. C., Snow K., Dixon J., Stapleton P. M., Faull R. L. M., Love D. R. Molecular analysis of the Huntington's disease gene in New Zealand. N. Z. med. J. 109:1996;27-30.
22. Zeitlin S., Liu J. P., Chapman D. L., Papaioannou V. E., Efstratiadis A. Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nature Genet. 11:1995;155-163.